Mayo Clinic Comprehensive Cancer Center is expanding surgical options for patients undergoing treatment or risk-reducing procedures for breast cancer through the adoption of robotic nipple-sparing mastectomy (NSM) at its Minnesota and Florida campuses. Following recent Food and Drug Administration clearance of the use of this platform for these procedures, Mayo Clinic surgeons are now offering a minimally invasive approach. This is designed to improve cosmetic outcomes, preserve skin and nipple viability, and broaden opportunities for potential sensory restoration.
A refined approach to mastectomy and reconstruction through robotic nipple-sparing mastectomy
NSM preserves the nipple-areolar complex and healthy breast skin, creating a more natural-appearing reconstructed breast after reconstruction. The improved cosmetic result can offer meaningful psychological benefits for patients compared with a traditional mastectomy result. However, many patients continue to experience visible scarring, diminished or absent sensation in the breast and nipple, and risk of loss of nipple or skin due to low blood flow.
